MedTrace Logo

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

NCT02166983 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-11-24

No results posted yet for this study

Summary

This randomized clinical trial studies cognitive enhancement program in improving cognitive function in breast cancer survivors. A cognitive enhancement program may help improve cognitive function in breast cancer survivors and may help doctors plan better treatment for cognitive decline.

Conditions

Interventions

OTHER

computer-assisted cognitive training

Complete Lumosity cognitive exercises

OTHER

cognitive intervention

Complete Active Journaling cognitive exercises

PROCEDURE

mind-body intervention procedure

Complete relaxation exercises

OTHER

memory intervention

Complete compensatory strategies

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Shelli Kesler · Stanford University Hospitals and Clinics

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02166983 on ClinicalTrials.gov